HKMPY (Hikma Pharmaceuticals) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKMPY Hikma Pharmaceuticals PLC HKMPY
88 GF Score
Price $41.31
GF Value $56.72
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hikma Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HKMPY
88GF Score
Hikma Pharmaceuticals PLC HKMPY
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hikma Pharmaceuticals (HKMPY) Overvalued in 2026?

Based on GuruFocus' analysis, Hikma Pharmaceuticals stock appears to be undervalued. The current stock price of $41.31 is trading 27.2% below its estimated GF Value™ of $56.72. GuruFocus considers Hikma Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for HKMPY:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $56.72 vs. price of $41.31 (27.2% below fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the HKMPY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hikma Pharmaceuticals Business Description

Address 10 Portman Square, London, GBR, W1H 6AZ
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets generic, branded, and in-licensed medicines. It operates through three segments: Injectables, which supplies hospitals with generic injectable products; Generics, which sells oral generic medicines primarily in the United States; and Branded, which markets branded and in-licensed pharmaceuticals across the Middle East and North Africa. The company's customers include hospitals, wholesalers, pharmacies, and healthcare providers. Geographically, North America is its largest market, followed by the Middle East and North Africa, Europe, and the United Kingdom. Hikma generates revenue mainly through product sales, supplemented by contract manufacturing and licensing arrangements, and operates manufacturing facilities in the United States, Europe, the Middle East, and North Africa.
88GF Score

Get the complete analysis for HKMPY

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.31
Price
$56.72
GF Value